Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AIMT

Aimmune Therapeutics (AIMT)

Aimmune Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AIMT
DateTimeSourceHeadlineSymbolCompany
26/02/202101:00Business WireAimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 YearsNASDAQ:AIMTAimmune Therapeutics Inc
17/02/202108:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AIMTAimmune Therapeutics Inc
21/12/202017:15Business WireEuropean Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EUNASDAQ:AIMTAimmune Therapeutics Inc
24/10/202004:12Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:AIMTAimmune Therapeutics Inc
20/10/202008:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
15/10/202007:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202008:32Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202008:31Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202008:31Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202008:30Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202008:30Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202008:30Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202008:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202008:29Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202001:49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202001:45Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202001:45Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202000:15Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202017:15Dow Jones NewsNestle Completes Purchase of Aimmune Therapeutics Shares; Plans Merger With SubsidiaryNASDAQ:AIMTAimmune Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AIMT